Vibatryp-H Tablet
By Vibatryp-H
Rx
10 Tablet in a Strip

Composition
Amitriptyline(12.5mg) + Chlordiazepoxide(5mg)

Manufacturer - Vibcare Pharma Pvt Ltd
Plot No 4, HSIIDC IT PARK,Sector 22, Panchkula, Haryana 134109

Expires on or after
August, 2025

liver
When using Vibatryp-H Tablet, caution should be exercised in patients with liver disease. It may be necessary to adjust the dosage of Vibatryp-H Tablet in such cases. It is important to consult your doctor regarding the use of this medication if you have any liver issues.

kidney
Limited data suggests Vibatryp-H Tablet is likely safe for patients with kidney disease. Dose adjustment may not be necessary. Consult your doctor for guidance.

alcohol
It is unsafe to drink alcohol while taking Vibatryp-H Tablet. Avoid alcohol intake with this medication.

driving
Caution should be taken while driving as Vibatryp-H Tablet may cause drowsiness and affect concentration, potentially impacting your driving ability.

pregnancy
Vibatryp-H Tablet is considered unsafe during pregnancy due to potential risks to the developing baby. However, in life-threatening situations, a doctor may prescribe it if benefits outweigh risks. Always consult your doctor before using.

breastfeeding
Caution is advised when breastfeeding while taking Vibatryp-H Tablet as it may not be safe. Limited data indicates the drug may pass to the baby through breastmilk, potentially causing harm.
Habit Forming | Yes |
Chemical Class | - |
Therapeutic Class | NEURO CNS |
Action Class | - |
₹37
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024